Join us in celebrating National Health Center Week, August 9-15, 2020! Community Health Center Physicians Utilizing Rapid, Non-Invasive Exam to Identify and Monitor People Living with “Silent” Liver Disease In…
Read More
This June 12, 2020, on International NASH Day, Echosens joins healthcare leaders to increase awareness about non-alcoholic steatohepatitis (NASH) among the general public, at-risk patients, the medical community, public health…
Underscore Need for Early Detection Many of us are familiar with liver disease caused by excessive alcohol intake, but with the increasing rates of Type 2 diabetes and obesity, non-alcoholic…
May is Hepatitis Awareness Month and Echosens is calling for increased vigilance and attention to the millions of Americans from all walks of life who are living with the most common causes of viral hepatitis: hepatitis B virus (HBV) and hepatitis C virus (HCV). People with chronic HBV may be at significantly increased risk of disease progression due to non-alcoholic fatty liver disease (NAFLD), which affects 1:3 Americans.
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of the disease characterized by the accumulation of lipids in liver cells not associated with the consumption of alcohol. It causes cellular dysfunction and, in some patients, leads to non-alcoholic steatohepatitis (NASH), fibrosis, and cirrhosis.
Celebrated every year in April, National Minority Health Month is an effort to raise awareness about health disparities that continue to affect racial and ethnic minority populations. During this time, Echosens is highlighting the impact of non-alcoholic fatty liver disease (NAFLD) and its more severe from nonalcoholic steatohepatitis (NASH) on minority populations.
The month of April is National Alcohol Awareness Month in America, and an excellent time to raise awareness about alcohol addiction, its causes, treatments, and impact on overall health.
Echosens is highlighting the link between liver disease and diabetes and urging individuals and communities to help raise awareness about the impact of diabetes.
Echosens shares a mission with the Fatty Liver Foundation to reach into every community in America to ensure asymptomatic individuals receive the screening and care they need.
Non-alcoholic fatty liver disease (NAFLD), affects approximately 100 million individuals in the United States. Its more serious form is called non-alcoholic steatohepatitis (NASH). NAFLD affects approximately 25% of the worldwide population and as many as 6% are affected by NASH, with NASH prevalence expected to increase by 63% by 2030.
